Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Singular Genomics Systems, Inc.
| Metric | Singular Genomics Systems, Inc. OMICHealthcare |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $3M |
| Net income (latest) | −$95M |
| Operating margin | −3531.5% |
| Net margin | −3257.3% |
| Return on equity | −53.0% |
| Return on assets | −35.7% |
| Return on capital (ROCE) | −41.6% |
| Debt / equity | 0.48× |
| Revenue growth (YoY) | 263.9% |
| Altman Z″ (distress) | -0.28 |
| Accruals / assets | −8.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.